centerforbiosimilars6d
Aflibercept Biosimilar MYL-1701P Provides Equivalence in DME Therapy
The study findings demonstrate that the aflibercept biosimilar MYL-1701P is as effective and safe as the reference ...
SC directive on case involving Zydus’ breast cancer biosimilar drug takes a fresh turn
Legal battle over Zydus' biosimilar breast cancer drug could impact generic competition, Supreme Court refuses interim relief.
ndtvprofit15d
Supreme Court Refuses To Revoke Injunction Against Sale Of Zydus Lifesciences' Breast Cancer Drug
In July, a single-judge bench of the Delhi High Court restrained Zydus Lifesciences from selling its breast cancer drug in ...
Pharmabiz1mon
Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima
The Division Bench of the Delhi High Court (HC), on October 16, 2024, reinstated the injunction preventing Zydus from manufacturing, selling, or marketing its breast cancer drug Sigrima, a biosimilar ...
Business Wire1mon
US FDA Approves Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA
SEOUL, South Korea--(BUSINESS WIRE)--Dong-A ST (President/CEO Jae-Hun Jung, KRX: 170900) announced on October 11 that Imuldosaâ„¢ (ustekinumab-srlf/DMB-3115), a ...